BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 6312126)

  • 1. [Abnormal hormone receptors in functional pituitary adenoma].
    Takeda R; Kawato M; Nakabayashi H; Imamura T; Seta T; Miyamori I
    Nihon Rinsho; 1983 Jun; 41(6):1259-63. PubMed ID: 6312126
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlative studies between the presence of thyrotropin-releasing hormone (TRH) receptors and the in vitro stimulation of growth-hormone (GH) secretion in human GH-secreting adenomas.
    Le Dafniet M; Garnier P; Bression D; Brandi AM; Racadot J; Peillon F
    Horm Metab Res; 1985 Sep; 17(9):476-9. PubMed ID: 2864309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin and prolactin binding sites in human breast cancer cells.
    Marchetti E; Rimondi AP; Querzoli P; Fabris G; Nenci I
    Prog Clin Biol Res; 1984; 142():109-17. PubMed ID: 6324233
    [No Abstract]   [Full Text] [Related]  

  • 4. Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: cloning and functional expression of the human thyrotropin-releasing hormone receptor gene.
    Yamada M; Monden T; Satoh T; Satoh N; Murakami M; Iriuchijima T; Kakegawa T; Mori M
    Biochem Biophys Res Commun; 1993 Sep; 195(2):737-45. PubMed ID: 8396925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemistry of pituitary adenoma].
    Kameya T; Tsumuraya M
    Nihon Rinsho; 1986 Mar; 44(3):633-7. PubMed ID: 3016371
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoradiographic localization of thyrotropin releasing hormone receptors in human brain.
    Manaker S; Eichen A; Winokur A; Rhodes CH; Rainbow TC
    Neurology; 1986 May; 36(5):641-6. PubMed ID: 3010178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Abnormal receptors in parathyroid hormone-secreting tumors].
    Fujita T
    Nihon Rinsho; 1983 Jun; 41(6):1270-4. PubMed ID: 6312128
    [No Abstract]   [Full Text] [Related]  

  • 8. [TRH, its function and receptor].
    Saito S; Oshima L
    Nihon Rinsho; 1981 Sep; 39(9):2921-7. PubMed ID: 6279921
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma.
    Eiler H; Oliver JW; Andrews FM; Fecteau KA; Green EM; McCracken M
    J Am Vet Med Assoc; 1997 Jul; 211(1):79-81. PubMed ID: 9215417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids down-regulate somatostatin receptors on pituitary cells in culture.
    Schonbrunn A
    Endocrinology; 1982 Apr; 110(4):1147-54. PubMed ID: 6120829
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of pituitary apoplexy during TRH/GnRH test in a patient with pituitary macroadenoma.
    Kılıçlı F; Dökmetaş HS; Gürelik M
    Singapore Med J; 2010 Nov; 51(11):e179-81. PubMed ID: 21140103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a silent pituitary somatotropic adenoma based on a paradoxic response of growth hormone on a thyrotropin-releasing hormone or gonadotropin-releasing hormone provocation test.
    Matsuno A; Ogino Y; Katayama H; Osamura RY; Nagashima T
    Am J Obstet Gynecol; 2001 Feb; 184(3):286-8. PubMed ID: 11228475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of chromogranin in human hypophyses and pituitary adenomas.
    Lloyd RV; Wilson BS; Kovacs K; Ryan N
    Arch Pathol Lab Med; 1985 Jun; 109(6):515-7. PubMed ID: 2986572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of thyrotropin-releasing hormone with analogs: influence of disposition upon pharmacology.
    Hichens M
    Drug Metab Rev; 1983; 14(1):77-98. PubMed ID: 6301791
    [No Abstract]   [Full Text] [Related]  

  • 15. Subclinical adenomas of the human pituitary. New light on old problems.
    McComb DJ; Ryan N; Horvath E; Kovacs K
    Arch Pathol Lab Med; 1983 Sep; 107(9):488-91. PubMed ID: 6309114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal hormone receptors in adrenal cortex tumors].
    Nawata H; Ibayashi H
    Nihon Rinsho; 1983 Jun; 41(6):1264-9. PubMed ID: 6312127
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of peptide binding to specific receptors on rat pituitary cells by tumor-promoting phorbol esters: decreased binding of thyrotropin-releasing hormone and somatostatin as well as epidermal growth factor.
    Osborne R; Tashjian AH
    Cancer Res; 1982 Nov; 42(11):4375-81. PubMed ID: 6127158
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on pituitary function in patients with B-cell adenoma.
    Zaccaria M; Giordano G; Vettor R; Ragazzi E; Boscaro M; Federspil G; Scandellari C
    Horm Metab Res; 1983 Nov; 15(11):562-3. PubMed ID: 6317536
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid temperature-dependent transformation of the thyrotropin-releasing hormone-receptor complex in rat pituitary tumor cells.
    Hinkle PM; Kinsella PA
    J Biol Chem; 1982 May; 257(10):5462-70. PubMed ID: 6279601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.